Characteristics n (508) | CHD group n (254) | no CHD group n (254) | p value |
---|---|---|---|
Age, yrs | 72.7āĀ±ā9.9 | 73.2āĀ±ā9.3 | 0.591 |
Female, % | 22.4 | 26.0 | 0.406 |
Diabetes mellitus, % | 64.6 | 63.0 | 0.712 |
BMI, kg/m2 | 23.0āĀ±ā3.5 | 23.3āĀ±ā4.0 | 0.485 |
eGFR, ml/min/1.73Ā m2 | 6.4āĀ±ā3.1 | 6.0āĀ±ā2.5 | 0.062 |
Creatinine, mg/dL | 7.85āĀ±ā2.51 | 8.09āĀ±ā2.45 | 0.260 |
BUN, mg/dL | 88.2āĀ±ā29.0 | 88.7āĀ±ā29.1 | 0.862 |
Hemoglobin, g/dL | 9.4āĀ±ā1.4 | 9.3āĀ±ā1.5 | 0.355 |
Albumin, g/dL | 3.14āĀ±ā0.58 | 3.16āĀ±ā0.56 | 0.738 |
Uric acid, mg/dL | 8.8āĀ±ā2.7 | 8.5āĀ±ā2.4 | 0.146 |
Potassium, mEq/L | 4.5āĀ±ā0.8 | 4.6āĀ±ā0.9 | 0.238 |
Adjusted calcium, mg/dL | 8.7āĀ±ā0.9 | 8.6āĀ±ā1.0 | 0.193 |
Phosphorus, mg/dL | 5.7āĀ±ā1.5 | 6.0āĀ±ā1.7 | 0.050 |
LDL-cholesterol, mg/dL | 83āĀ±ā32 | 83āĀ±ā33 | 0.992 |
HDL-cholesterol, mg/dL | 41āĀ±ā14 | 46āĀ±ā17 | 0.003 |
Triglyceride, mg/dL | 125āĀ±ā96 | 111āĀ±ā46 | 0.059 |
CRP, mg/dL | 2.0āĀ±ā3.3 | 2.0āĀ±ā4.4 | 0.946 |
Use of ARBs or ACEIs, % | 61.8 | 60.2 | 0.785 |
Use of Ī²-blockers, % | 55.9 | 48.4 | 0.109 |
Use of anti-platelet agents, % | 74.0 | 28.7 | <0.001 |
Use of warfarin, % | 13.0 | 11.0 | 0.586 |
Use of loop diuretics, % | 77.2 | 74.0 | 0.408 |
Use of statins, % | 66.1 | 63.8 | 0.642 |
Use of ESAs | 84.6 | 87.8 | 0.235 |